SOLACI es la organización de referencia del intervencionismo cardiovascular latinoamericano.

Últimas Noticias

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Dr. Juan Manuel Pérez - 31 March, 2026 0

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Dr. Juan Manuel Pérez - 31 March, 2026 0

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Dr. Juan Manuel Pérez - 31 March, 2026 0

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...

Noticias Institucionales

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

solaci - 6 April, 2026 0

The Latin American Society of Interventional Cardiology (SOLACI) invites the community to the 5th International Conference on Clinical and Interventional Cardiology (Coronary and Structural),...

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

solaci - 31 March, 2026 0

The call for submissions is now open to participate in the Young Interventional Cardiologists Competition at the Panama 2026 Regional Meeting, which will take...

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

solaci - 29 March, 2026 0

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

Accesos

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Términos de uso -Políticas de privacidad

Tag: Conduction Disorders

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

TRIPLACE Registry: Conduction Disorders Following Transcatheter Tricuspid Valve Replacement

Conduction Disorders in TAVR: Is Colchicine Useful?

Immediate Electrocardiography After TAVI, the Simplest Way to Predict Conduction Disorders

Últimas Noticias

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Noticias Institucionales

SOLACI invites you to the 5th International Conference on Clinical and Interventional Cardiology in the Dominican Republic

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Accesos